Main Article Content
Abstract
In terms of giving proficient administrations, the pharmacy profession has extended altogether and is presently recognized as fundamental to the multidisciplinary conveyance of wellbeing care. Since drug specialists are vital healthcare experts who progress persistent care and energize wellness, their position in society's healthcare is vital. Drug specialists are sometimes referred to as chemists and druggists in the therapeutic field. Drug specialists work with solutions and donate exact data approximately them. They moreover assist in the generation, detailing, quality control, standardization, compounding and apportioning of different dose shapes so that they can be utilized to treat a variety of maladies. In the healthcare framework, the drug specialist works in various ways, such as Investigate and Improvement (R&D) segment, creating new drug definitions, and keeping up legitimate security and poisonous quality of the drugs. The drug specialist is vital for the slight elderly populace in essential care. The part of drug specialists has been growing around the Globe, in the present time, as an case the COVID-19 widespread. In pith, drug specialists are essential to the wellbeing care framework. The article makes a difference distinguish pharmacists' various parts in diverse healthcare framework areas to create a healthier world., which is all emphasize themes of protection, royal authority, and well-being. It is also believed to be an abbreviation for the Latin word "recipe," meaning "Take" (referring to the medicine). Additionally, the symbol is associated with the zodiac sign of Jupiter.
Keywords
Article Details
References
- 1. Nicola H: The global pharmacy work force: Systematic review of the literature. Human Resource for Health 2009; 7(48): 1478–4491.
- 2. Kumar AY, Kumar RV, Ahmad A, Mohanta GP and Manna PK: Pharmacists interventions and pharmaceutical care in an Indian teaching hospital: A prospective study. Int J Adv Res Pharm Bio 2012; 1: 386–96.
- 3. Aziri B: Job Satisfaction: A Literature Review. Management Research and Practice 2011; 77–86.
- 4. Armstrong M: A Hand book of Human resource Management Practice. Kogan Page Publishing, London, Tenth Edition 2006.
- 5. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA: Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003; 163(17): 2014-8.
- 6. Makowsky MJ, Schindel TJ, Rosenthal M, Campbell K, Tsuyuki RT and Madill HM: Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting. J Inter prof Care 2009; 23(2): 169-84.
- 7. Farsaei S, Sabzghabaee AM, Zargarzadeh AH and Amini M: Effect of pharmacist-led patient education on glycaemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011; 16(1): 43-9.
- 8. Access to Medicines and Health Products. The importance of pharmacovigilance [Internet]. Who.int. World Health Organization; 2002. [cited 2021 Sep 15].
- 9. Arulmani R, Rajendran SD and Suresh B: Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacology 2008; 65(2): 210-6.
- 10. Pharm D. New Delhi; 10th May: Ministry of Health and Family Welfare (Pharmacy Council of India); 2008. [Last cited on 2013 May 27]. Regulations. The Gazette of India 2008; 19(3)4: 1-97.
- 11. Chauhan N, Moin S, Pandey A, Mittal A and Bajaj U: Indian aspects of drug information resources and impact of drug information centre on community. J Adv Pharm Technology Res 2013; 4(2): 84-93.
- 12. Asiri and Yousif A: Emerging frontiers of pharmacy education in Saudi Arabia: the metamorphosis in the last fifty years. Saudi Pharm J 2011; 19: 1–8.
- 13. Atkinson, Jeffrey, Nicholson, Jane, Rambaut and Bart: Survey of pharmaceutical education in Europe, Pharm in e – report on the integration of the industry component in pharmacy education and training. EIP 2012; 1: 3–7.
- 14. Bone A: The conference. The industry perspective – a wide variety of positions. Pharmaceutical J 1999; 263: 647– 648.
- 15. Kjekshus J: Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007; 357: 2248-61.
- 16. Hasan SS, Kwai Chong, DW, Ahmadi K, Se WP, Hassali MA and Hata EM: Influences on Malaysian pharmacy students‟ career preferences. Am J Pharm Education 2010; 74: 166.
- 17. Merz T and Fuller S: Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone. Am J Health Cyst Pharm 2007; 64: 1818-21.
- 18. Khan FY: Rosuvastatin induced rhabdomyolysis in a low riskpatient: a case report and review of the literature. Curr Clin Pharmacal 2009; 4: 1-3.
- 19. Hua X, Gu M and Zeng F: Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. JAPAs 2020; 60: 431–438.
- 20. Simpson SH: The roles we have as hospital pharmacists. Can J Hosp Pharm 2017; 70: 3-4. 29.
- 21. Chamoun N, Usta U and Karaoui LR: Current Trends in Hospital Pharmacy Practice in Lebanon. Hosp Pharm 2020; 55: 112-118.
- 22. Pilkington EM: The role of the general practice pharmacist in health education and health maintenance. Health Educ J 1979; 37: 187-192.
- 23. Gupta V, Hincapie AL and Frausto S: Impact of a web-based intervention on the awareness of medication adherence. Res Social Adm Pharm 2016; 12: 926-936.
References
1. Nicola H: The global pharmacy work force: Systematic review of the literature. Human Resource for Health 2009; 7(48): 1478–4491.
2. Kumar AY, Kumar RV, Ahmad A, Mohanta GP and Manna PK: Pharmacists interventions and pharmaceutical care in an Indian teaching hospital: A prospective study. Int J Adv Res Pharm Bio 2012; 1: 386–96.
3. Aziri B: Job Satisfaction: A Literature Review. Management Research and Practice 2011; 77–86.
4. Armstrong M: A Hand book of Human resource Management Practice. Kogan Page Publishing, London, Tenth Edition 2006.
5. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA: Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003; 163(17): 2014-8.
6. Makowsky MJ, Schindel TJ, Rosenthal M, Campbell K, Tsuyuki RT and Madill HM: Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting. J Inter prof Care 2009; 23(2): 169-84.
7. Farsaei S, Sabzghabaee AM, Zargarzadeh AH and Amini M: Effect of pharmacist-led patient education on glycaemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011; 16(1): 43-9.
8. Access to Medicines and Health Products. The importance of pharmacovigilance [Internet]. Who.int. World Health Organization; 2002. [cited 2021 Sep 15].
9. Arulmani R, Rajendran SD and Suresh B: Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacology 2008; 65(2): 210-6.
10. Pharm D. New Delhi; 10th May: Ministry of Health and Family Welfare (Pharmacy Council of India); 2008. [Last cited on 2013 May 27]. Regulations. The Gazette of India 2008; 19(3)4: 1-97.
11. Chauhan N, Moin S, Pandey A, Mittal A and Bajaj U: Indian aspects of drug information resources and impact of drug information centre on community. J Adv Pharm Technology Res 2013; 4(2): 84-93.
12. Asiri and Yousif A: Emerging frontiers of pharmacy education in Saudi Arabia: the metamorphosis in the last fifty years. Saudi Pharm J 2011; 19: 1–8.
13. Atkinson, Jeffrey, Nicholson, Jane, Rambaut and Bart: Survey of pharmaceutical education in Europe, Pharm in e – report on the integration of the industry component in pharmacy education and training. EIP 2012; 1: 3–7.
14. Bone A: The conference. The industry perspective – a wide variety of positions. Pharmaceutical J 1999; 263: 647– 648.
15. Kjekshus J: Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007; 357: 2248-61.
16. Hasan SS, Kwai Chong, DW, Ahmadi K, Se WP, Hassali MA and Hata EM: Influences on Malaysian pharmacy students‟ career preferences. Am J Pharm Education 2010; 74: 166.
17. Merz T and Fuller S: Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone. Am J Health Cyst Pharm 2007; 64: 1818-21.
18. Khan FY: Rosuvastatin induced rhabdomyolysis in a low riskpatient: a case report and review of the literature. Curr Clin Pharmacal 2009; 4: 1-3.
19. Hua X, Gu M and Zeng F: Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. JAPAs 2020; 60: 431–438.
20. Simpson SH: The roles we have as hospital pharmacists. Can J Hosp Pharm 2017; 70: 3-4. 29.
21. Chamoun N, Usta U and Karaoui LR: Current Trends in Hospital Pharmacy Practice in Lebanon. Hosp Pharm 2020; 55: 112-118.
22. Pilkington EM: The role of the general practice pharmacist in health education and health maintenance. Health Educ J 1979; 37: 187-192.
23. Gupta V, Hincapie AL and Frausto S: Impact of a web-based intervention on the awareness of medication adherence. Res Social Adm Pharm 2016; 12: 926-936.